Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prasanta Dutta

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Journal of Experimental Medicine|August 30, 2020
Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancerYu Zhang, Vidhi Chandra, Erick Riquelme Sanchez, et al.
Cancer Immunology Research|September 12, 2020
Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic PhenotypeAshvin R Jaiswal, Arthur J Liu, Shivanand Pudakalakatti, et al.
Cancer & Metabolism|January 31, 2015
Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302Jonathan W Wojtkowiak, Heather C Cornnell, Shingo Matsumoto, et al.
Iscience|February 24, 2023
Exploiting metabolic vulnerabilities after anti-VEGF antibody therapy in ovarian cancerDeanna Glassman, Mark S Kim, Meredith Spradlin, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Journal of Experimental Medicine|August 30, 2020
Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancerYu Zhang, Vidhi Chandra, Erick Riquelme Sanchez, et al.
Cancer Immunology Research|September 12, 2020
Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic PhenotypeAshvin R Jaiswal, Arthur J Liu, Shivanand Pudakalakatti, et al.
Cancer & Metabolism|January 31, 2015
Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302Jonathan W Wojtkowiak, Heather C Cornnell, Shingo Matsumoto, et al.
Iscience|February 24, 2023
Exploiting metabolic vulnerabilities after anti-VEGF antibody therapy in ovarian cancerDeanna Glassman, Mark S Kim, Meredith Spradlin, et al.
Pageof 3